Nanobiose Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Nanobiose General Information

Description

Developer of lab-on-a-chip technology designed to provide tools to enhance vitro analysis of efficacy for drug candidates. The company's platform combines a microfluidic biochip and a removable biosensor for a multiplexed online biomarkers analysis, enabling medical researchers to bring out accurate and predictive results for evaluating drug candidates at early stages.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 354 Voie Magellan
  • Parc d'Activités Alpespace
  • 73800 Sainte-Helene-du-Lac
  • France
+33 04
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Other Healthcare Technology Systems
Corporate Office
  • 354 Voie Magellan
  • Parc d'Activités Alpespace
  • 73800 Sainte-Helene-du-Lac
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobiose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 12-Apr-2024 Completed Out of Business
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Nanobiose’s complete valuation and funding history, request access »

Nanobiose Patents

Nanobiose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3075823-A1 Method of analyzing a cellular sample using a micro-fluidic chip laboratory Inactive 21-Dec-2017
FR-3075817-A1 Micro-fluidic chip and laboratory on micro-fluidic chip Active 21-Dec-2017
FR-3075817-B1 Micro-fluidic chip and laboratory on micro-fluidic chip Inactive 21-Dec-2017
EP-3728556-A1 Microfluidic chip, microfluidic lab-on-a-chip, method for producing such a chip and analysis method Inactive 21-Dec-2017
WO-2019122788-A1 Microfluidic chip, microfluidic lab-on-a-chip, method for producing such a chip and analysis method Inactive 21-Dec-2017 B01L3/502776
To view Nanobiose’s complete patent history, request access »

Nanobiose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanobiose FAQs

  • When was Nanobiose founded?

    Nanobiose was founded in 2016.

  • Where is Nanobiose headquartered?

    Nanobiose is headquartered in Sainte-Helene-du-Lac, France.

  • What is the size of Nanobiose?

    Nanobiose has 5 total employees.

  • What industry is Nanobiose in?

    Nanobiose’s primary industry is Biotechnology.

  • Is Nanobiose a private or public company?

    Nanobiose is a Private company.

  • What is Nanobiose’s current revenue?

    The current revenue for Nanobiose is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process